Vancouver, British Columbia – October 10, 2025 – TheNewswire -  Pangea Natural Foods Inc. (CSE: PNGA) (OTC: PNGAF) (“Pangea” or the “Company”), is pleased to announce that its wholly owned subsidiary, Amino Innovations, is expanding its market presence through sponsorships and featured exhibitions at three high-profile health and longevity events this October.

 

MoreLife Biohacking Summit, October 11-12, 2025 | Fort Lauderdale, Florida
Amino Innovations is proud to sponsor and exhibit at the MoreLife Biohacking Summit, one of the fastest growing conferences in the global longevity movement. This year’s summit features keynote speakers Gary Brecka, renowned human biologist and founder of The Ultimate Human; Lara Trump, wellness advocate and former Co-Chair or the Republican National Committee; and Tito Ortiz, UFC Hall of Famer and early biohacker. The event brings together entrepreneurs, athletes, and wellness professionals focused on health optimization and human performance.

 

The Healthspan Summit, October 3-5, 2025 | Los Angeles, California

Earlier this month, Amino Innovations sponsored and exhibited at the Healthspan Summit, a leading forum for cellular medicine and regenerative health innovation. The event featured notable speakers including Dr. William Seeds, a pioneer in peptide and cellular repair science; David Perez, a leader in regenerative and functional medicine; and Dr. Stephanie Venn-Watson, physician-scientist and longevity expert. Participation at the Healthspan Summit provided an opportunity to connect with leading clinicians, wellness entrepreneurs, and investors focused on advancing peptide science and next-generation therapeutic delivery systems.

 

Both summits provided Amino Innovations with a platform to actively showcase its non-injectable peptide products to an engaged audience of health professionals and performance enthusiasts. Live demonstrations and in-person discussions allowed attendees to experience the convenience and efficacy of Amino’s delivery formats firsthand, sparking strong interest from clinic operators, athletes, and wellness influencers. The company’s presence across these two events positioned Amino as an emerging innovator and reinforced its mission to make “Peptides, Reimagined” a reality within the global market.

Disrupt Business 2025, October 17-19, 2025 | Orlando, California

Amino Innovations is also excited to announce that Co-Founder and Chief Science Officer Justin Kirkland will be a featured speaker at Disrupt Business 2025, a leading conference for health practitioners and wellness entrepreneurs. His session will explore needle-free peptide delivery systems and bioavailable formulations, offering a preview of Amino Innovations upcoming peptide patch launch and its potential to redefine convenient, at-home peptide therapy.

About Pangea Natural Foods Inc.

Pangea Natural Foods Inc. is a North American manufacturer specializing in clean-label foods and innovative wellness products. Through its subsidiary Amino Innovations, the Company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.

 

On Behalf of the Board of Directors

"Pratap Sandhu"

Pratap Sandhu
CEO, Corporate Secretary and Director

+1 (604) 765-8069

Forward-Looking Information

This news release contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. The forward–looking statements and information are based on certain key expectations and assumptions made by the management of the Company. As a result, there can be no assurance that the acquisition or related matters will be completed as proposed or at all. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward–looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward–looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the ability of the Company to complete its planned future activities and anticipated business plans. Other factors may also adversely affect the future results or performance of the Company, including general economic, market or business conditions, changes in the financial markets and changes in laws, regulations and policies affecting the Company's operations and the Company's limited operating history. Accordingly, readers should not place undue reliance on the forward–looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward– looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward–looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.